Data Minimization: Balancing GDPR & Research Insights
Data minimization is one of the fundamental principles of the General Data Protection Regulation (GDPR), aimed at ensuring that...
Diana Andrade
Top 3 GDPR Compliance Questions in Clinical Trials
In the fast-evolving world of clinical trials, GDPR compliance is more than a legal obligation—it’s a pillar of trust,...
Dynamic Consent: A New GDPR Standard for Clinical Trials
In an era where data is the cornerstone of innovation, the concept of dynamic consent is emerging as a...
Navigating IP in Clinical Trials: Insights from Joana Piriquito Santos
In the high-stakes world of pharmaceuticals, intellectual property (IP) rights are crucial for protecting innovation and ensuring returns on...
GDPR Class Actions: Compliance now for Trial Sponsors
On December 1, 2024, the European non-profit organization noyb (None of Your Business), co-founded by privacy advocate Max Schrems,...
Privacy Now: Balancing Innovation and Privacy in Genomics
The UK’s Information Commissioner’s Office (ICO) recently issued a critical call for collaboration in genomics, emphasizing the need to...
How GDPR Drives Trust in Patient-Centric Trials
In recent years, patient-centric trial designs have emerged as a transformative approach in clinical research, placing patients at the...
New EDPB Opinion: Vendors in Clinical Trials
The European Data Protection Board (EDPB) recently issued Opinion 24/2024, focusing on a critical aspect of data protection compliance:...
Transparency and Anonymization in Research: EMA Guidelines
As the clinical trial landscape evolves under the EU Clinical Trials Regulation (CTR), transparency and privacy have become central...
EHDS & GDPR Compliance: Urgent Action Needed for Biopharma
In the rapidly evolving landscape of health data regulation, the European Health Data Space (EHDS) initiative marks a transformative...